top of page

MiBo ThermoFlo®: A Gentle, In-Office Approach to Meibomian Gland Dysfunction

Writer: Lumenis Eyecare & Wellness
Lumenis Eyecare & Wellness
Oct 1
4 min read

Dry, burning, watery, or tired eyes are not always caused by a lack of tears. For many people, the problem begins with the tiny oil-producing glands inside the eyelids. When these meibomian glands become blocked or stop releasing healthy oil, tears evaporate too quickly and the eyes may feel irritated throughout the day.


MiBo ThermoFlo®—also known as MiBoFlo®—is a comfortable, noninvasive, in-office treatment designed to support meibomian gland function. The device combines controlled external heat with gentle eyelid massage to soften thickened oils and encourage healthier meibum flow.


Why the Meibomian Glands Matter

Every time you blink, the meibomian glands release a thin layer of oil called meibum onto the surface of the eye. This oil forms the outer layer of the tear film and helps slow tear evaporation.


When the glands become obstructed, the oil may grow thick or stop flowing properly. This condition is known as meibomian gland dysfunction, or MGD, and it is a common contributor to evaporative dry eye.


Possible symptoms include:

  • Burning, stinging, or gritty eyes

  • Redness or irritation

  • Excessive watering

  • Fluctuating or blurry vision

  • Eye fatigue, especially during screen use

  • Contact-lens discomfort

  • Eyelids that feel tender, heavy, or inflamed

  • Recurrent eyelid bumps, such as styes or chalazia


Because several eye conditions can produce similar symptoms, a dry eye evaluation is important before treatment. Your eye doctor may assess the tear film, eyelid margins, gland structure, blink quality, and the amount and consistency of oil expressed from the glands.


How MiBo ThermoFlo Works

MiBo ThermoFlo uses thermoelectric technology to maintain a controlled treatment temperature of approximately 108°F (42°C). A smooth treatment pad is moved gently over the closed eyelids with ultrasound gel, transferring heat through the eyelid tissue while the clinician performs a controlled massage.


The combination is intended to:

  1. Warm thickened meibum inside the glands.

  2. Help the oil become more fluid.

  3. Encourage movement of meibum through the gland ducts.

  4. Support a healthier oil layer in the tear film.


Unlike a home warm compress, the device provides consistent heat throughout the treatment while a trained provider directs the massage to the eyelids. Depending on the patient’s findings and the practice’s protocol, the clinician may perform additional gland expression or combine MiBoFlo with other therapies.


What Happens During Treatment?

Before the session, patients are generally asked to remove contact lenses and eye makeup. Ultrasound gel is applied to the treatment pad, and the handpiece is gently moved across the closed upper and lower eyelids.


A typical treatment takes approximately 8–10 minutes per eye. Most patients describe the warmth and massage as comfortable and relaxing. There are no incisions or injections, and normal activities can usually be resumed after the appointment.


Many clinical protocols use a series of treatments—often four visits scheduled about two weeks apart—followed by reassessment. The exact number and timing of sessions should be based on the severity of the gland dysfunction, the patient’s response, and the treating clinician’s judgment. Maintenance treatment may be recommended because MGD is often chronic.


What Does the Clinical Evidence Show?

Published clinical studies have reported improvements in symptoms and meibomian gland function following MiBoFlo treatment. In a prospective randomized study comparing MiBoFlo with LipiFlow®, both groups improved from baseline in symptom scores and measures of gland function, with improvements maintained through the study’s two-month follow-up. Some measurements—including noninvasive tear breakup time, corneal staining, and gland loss—did not significantly change in that study.


Other published research has reported statistically and clinically significant improvements in signs and symptoms of MGD after a course of thermoelectric warming therapy. A 2024 retrospective comparison also reported greater improvement in several subjective and objective measures after a series of manual MiBoFlo treatments than after one automated LipiFlow treatment. Differences in treatment schedules and study design should be considered when interpreting that comparison.


These findings are encouraging, but results vary. MiBoFlo does not regenerate glands that have already atrophied, and it should not be presented as a guaranteed cure for dry eye. A complete evaluation is necessary to determine whether MGD is the primary problem and whether additional treatment is needed.


Who May Be a Candidate?

MiBo ThermoFlo may be considered for patients with signs and symptoms associated with obstructive MGD, including people who have not received enough relief from artificial tears or home warm compresses alone.


Treatment may also be incorporated into a broader dry eye plan that includes:

  • Eyelid hygiene and management of blepharitis or Demodex

  • Preservative-free lubricating drops

  • Omega-3 or nutritional recommendations when appropriate

  • Prescription anti-inflammatory therapy

  • Intense pulsed light or photobiomodulation when clinically indicated

  • Blink training, screen-use changes, and environmental modifications

  • Periodic gland evaluation and maintenance care


Not every dry eye patient is an appropriate candidate. Active infection, significant eyelid or ocular-surface inflammation, recent surgery, skin injury around the treatment area, or other eye conditions may require treatment first or a modified plan. The provider should review medical history, medications, symptoms, and examination findings before proceeding.


MiBoFlo Versus At-Home Warm Compresses

Home warm compresses can remain a valuable part of daily care, but their temperature may fall quickly and results depend heavily on consistent technique. MiBoFlo provides controlled, repeatable heat and clinician-directed massage during an in-office session.

The two approaches do not have to be mutually exclusive. Many patients continue an appropriate home-care routine between professional treatments to help manage a chronic condition.


Treat the Glands, Not Just the Symptoms

Artificial tears may temporarily lubricate the eyes, but they do not necessarily correct blocked meibomian glands. For patients whose dry eye is driven by poor oil flow, improving gland function may help create a more stable tear film and reduce rapid evaporation.


MiBo ThermoFlo offers a gentle, noninvasive way to address the meibomian glands directly through controlled warming and massage. The first step is a comprehensive dry eye evaluation to identify the cause of the symptoms and build the right treatment sequence.


Ready to learn whether MiBo ThermoFlo is right for you? Schedule a dry eye evaluation with our team today.

Medical disclaimer: This article is for educational purposes only and does not replace an examination, diagnosis, or individualized treatment advice from a licensed eye-care professional. Outcomes and treatment schedules vary by patient.

Comments


OFFICE HOURS

Monday

10 am - 6 pm

Tuesday

Closed

Wednesday

Thursday

10 am - 6 pm

10 am - 6 pm

Friday

Saturday

Closed

10 am  - 1 pm

(by appointment)

Sunday

Closed

APPOINTMENTS

We will do our best to accommodate your schedule. 

CONTACT US

16151 Weber Road, Suite 103

Crest Hill, IL 60403

© 2026 by Lumenis Eye Care & Wellness | Privacy Policy & SMS ToS | Powered by Barti Software

bottom of page